The Leukemia and Lymphoma Society (LLS) National Research Registry

Launched by LYMPHOMA AND LEUKEMIA SOCIETY · Mar 16, 2021

Keywords

ClinConnect Summary

The Leukemia and Lymphoma Society (LLS) National Research Registry is a clinical trial aimed at understanding the real-life experiences and health outcomes of individuals with blood cancer. This study looks at patients at different stages of their treatment journey, whether they are newly diagnosed, currently undergoing treatment, or recovering after treatment. By gathering this information, researchers hope to improve care and support for people affected by blood cancer.

To participate in this study, you need to be someone diagnosed with blood cancer, at any point in your treatment process. Unfortunately, if you are unable or unwilling to sign an informed consent form, you won't be able to join. If you decide to take part, you can expect to share your experiences and medical outcomes, which will help researchers better understand how to help people with blood cancer. This study is currently looking for participants of all ages, including those over 70, and welcomes individuals of any gender. Your involvement could make a meaningful difference in the lives of others facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • People with blood cancer, before, during, and after blood cancer treatments.
• Exclusion Criteria:
• • People unable or unwilling to sign informed consent.